Latest Updates About BIRAD-Related Research
A Strategic Leap Toward a Sustainable Energy Future
In a milestone event for Israeli innovation, Minister of Energy and Infrastructure Eli Cohen and Bar-Ilan University President Prof. Arie Zaban officially inaugurated the National Institute for Electrochemical Energy Storage, established at Bar-Ilan University in collaboration with the Technion – Israel Institute of Technology. The institute—Israel’s first of its kind—is set to play a central role in developing…
Read More
Pluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation Authority
HAIFA, Israel – October 28, 2024 – Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) (“Pluri” or the “Company”), a leading biotechnology company that transforms cells into solutions, today announced that the Israel Innovation Authority (“IIA”) will fund Pluri’s collaboration with the Bar-Ilan University Research and Development Company Ltd., (“BIRAD”), the commercial arm of Bar-Ilan University, to support the continued…
Read More
A New Hero in the Fight Against Cancer
The innovative imaging technique that could change the game in our battle against this formidable foe: copper. A fascinating discovery is set to revolutionize cancer detection and treatment. Professor Sharon Ruthstein from the Department of Chemistry at BIU is pioneering an innovative imaging technique that could change the game in our battle against this formidable foe. Her secret weapon?…
Read More
Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine Addiction
HAIFA, Israel, December 21, 2023 – Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotech company that transforms cells into solutions that promote well-being and sustainability, announced it has signed an agreement assigning the joint patent rights to develop Pluri’s PLX cells in the treatment of cocaine addiction, to BIRAD–Research &…
Read More
חוקרים בכירים מהארץ והעולם בשילוב נציגים מהתעשייה לקחו חלק ב כנס NLP ו Networks באוניברסיטת בר-אילן
חוקרים בכירים מהארץ והעולם בשילוב נציגים מהתעשייה לקחו חלק בכנס שהתמקד השנה בשני תחומי מחקר בולטים: Natural Language Processing – NLP ו Networks. הכנס נערך ביוזמה משותפת של ביראד חברה למחקר ופיתוח והמכון למדעי הנתונים באוניברסיטת בר-אילן, ובחסות החברות אורקל וגוגל. מעל 350 אנשי אקדמיה ותעשיה נחשפו להרצאות מרתקות ודיונים אינטראקטיביים שהתקיימו במליאה ואפשרו חשיפה…
Read More
Reducing CO2 in the Air
Prof. Doron Aurbach of the BIU Department of Chemistry Department and his team have developed an innovative system which efficiently absorbs CO2 from the air and converts it into fertilizer for growing vegetables The echoes of war have pushed climate change to the margins of the news, but the many hot days in November and…
Read More
A New Milestone for Flexible Magnetic Sensors
A giant leap of more than an order of magnitude improvement in the sensitivity of flexible magneto-resistive sensors heralds new opportunities for flexible sensors in medical devices, soft robotics and more. Flexible magnetic sensors have gained popularity due to their versatility and potential applications in major areas of flexible electronics, including soft robotics, consumer electronics,…
Read More
Bar-Ilan University Hosts Conference for Managers of Scientific Infrastructure Centers in Israel
Significant Milestone Reached in Shaping the Future of Research Infrastructures Bar-Ilan University, Israel – Bar-Ilan University played host this week to the inaugural conference for managers of scientific infrastructure centers in Israel, marking a momentous occasion in advancing research infrastructures within the country. Organized by Bar-Ilan University’s Kanbar Center for Scientific Instrumentation, the conference gathered…
Read More
Hadassah Medical Organization and Bar-Ilan University Collaborate with Immix BioPharma for the Further Development and Commercialization of Next-Generation CAR-T Therapy
HBI0101, anti-BCMA CAR-T cells, showed 90% overall response rate in ongoing Phase 1b clinical trial with 50 relapsed/refractory multiple myeloma patients HBI0101 also demonstrated 100% overall response rate in 6 relapsed/refractory AL Amyloidosis patients Jerusalem & Ramat Gan, Israel – January 4, 2023 – Hadasit, the Innovation Engine of Hadassah Medical Organization and BIRAD, the…
Read More